AC Immune SA (ACIU)
NASDAQ: ACIU · IEX Real-Time Price · USD
2.370
-0.010 (-0.42%)
At close: Apr 24, 2024, 4:00 PM
2.350
-0.020 (-0.84%)
After-hours: Apr 24, 2024, 4:35 PM EDT

AC Immune Cash Flow Statement

Millions CHF. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014
Net Income
-54.23-70.75-73-61.9245.44-50.95-26.41-7.120.2710.74
Depreciation & Amortization
2.222.362.411.971.690.960.580.280.290.3
Share-Based Compensation
4.373.334.134.092.832.521.581.320.540.21
Other Operating Activities
-13.17-8.11.25-3.385.263.71.98-0.0622.94-28.89
Operating Cash Flow
-60.83-73.16-65.22-59.2555.23-43.77-22.27-5.5644.04-17.64
Capital Expenditures
-0.8-1.24-2.64-1.64-1.89-1.86-1.8-0.9-0.24-0.13
Change in Investments
66.4525-5130-65-300000
Other Investing Activities
-0-0.03-0.03--0.18-0.04---0
Investing Cash Flow
65.6523.76-53.6628.33-66.89-32.04-1.84-0.9-0.24-0.13
Share Issuance / Repurchase
43.8-017.80.14-0.44111.530.0769.6900
Debt Issued / Paid
-0.55-0.5722.95-0.9550.06-0.140.2000
Other Financing Activities
--0.78----2.02-9.127.789.8
Financing Cash Flow
43.25-1.3540.75-0.849.62109.380.2778.7927.789.8
Exchange Rate Effect
-1.580.52-0.07-0.7-0.83-1.18-4.173.441.60.01
Net Cash Flow
48.49-51.15-78.61-31.9937.9533.26-23.6772.2571.62-7.95
Free Cash Flow
-61.63-74.4-67.85-60.8953.34-45.63-24.07-6.4643.79-17.77
Free Cash Flow Margin
-416.38%-1890.67%--394.59%48.29%-660.16%-118.85%-27.84%112.03%-58.70%
Free Cash Flow Per Share
-0.73-0.88-0.93-0.850.79-0.80-0.42-0.131.01-0.42
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).